Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jolanta Kryczka
Institution:
Medical University of Lodz
Observed institution:
Medical University of Lodz
ORCID:
0000-0002-7342-7342
Observed ORCID:
0000-0002-7342-7342
OpenAlex ID:
A5010781253
Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy
2021
·
Jolanta Kryczka
, Jakub Kryczka
, et al.
·
International Journal of Molecular Sciences
·
200
PDF
Serum Extracellular Vesicle-Derived miRNAs in Patients with Non-Small Cell Lung Cancer—Search for Non-Invasive Diagnostic Biomarkers
2021
·
Jolanta Kryczka
, Monika Migdalska-Sęk
, et al.
·
Diagnostics
·
29
PDF
Isothiocyanates (ITCs) 1-(Isothiocyanatomethyl)-4-phenylbenzene and 1-Isothiocyanato-3,5-bis(trifluoromethyl)benzene—Aldehyde Dehydrogenase (ALDH) Inhibitors, Decreases Cisplatin Tolerance and Migratory Ability of NSCLC
2022
·
Jolanta Kryczka
, Jakub Kryczka
, et al.
·
International Journal of Molecular Sciences
·
12
A preliminary bioinformatic screen to identify SRI SMC2 PSIP1 TLE4 and MSX1 as potential diagnostic and prognostic markers of osteoarthritis
2025
·
Jolanta Kryczka
, Ewa Brzeziańska-Lasota
, et al.
·
Scientific Reports
·
1
PDF
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin
2026
·
Jolanta Kryczka
, Jakub Mateusz Kryczka
, et al.
·
Cancer Biology & Therapy
Show more works
View as search
Works count:
5
Citation count:
242
H-index:
3
I10-index:
3
Year
Topic
Type